NC
CARM

Nexthera Capital’s Carisma Therapeutics CARM Stock Holding History

Nexthera Capital’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-58,850
Closed -$2.53M – 29
2018
Q3 		$2.53M Buy
+58,850
New +$2.29M 0.49% 35

Other funds holding CARM

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
TG
TRV GP Boston, Massachusetts $18.9M AUM 541.67% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nexthera Capital's CARM Position: Q4 2018 in Review

Nexthera Capital sold out of Carisma Therapeutics (CARM) in Q4 2018, closing a stake of 58,850 shares — an estimated $2.53M sold.

Nexthera Capital first reported a position in CARM in Q3 2018 and held it in 1 quarter. The position peaked at $2.53M in Q3 2018. 48 funds tracked by Wall St. Rank hold CARM as of Q4 2018.

  • Nexthera Capital reported no remaining Carisma Therapeutics position as of Q4 2018 after selling out during the quarter.
  • Nexthera Capital sold 58,850 Carisma Therapeutics shares in Q4 2018, an estimated $2.53M.
  • Nexthera Capital first reported a position in Carisma Therapeutics in Q3 2018 and held it in 1 quarter.
  • Nexthera Capital's Carisma Therapeutics position peaked at $2.53M in Q3 2018.
  • 48 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2018.

Based on Nexthera Capital's 13F filing for Q4 2018, filed 14 Feb 2019.